Abiodun O. Aboaba

Catheter Ablation vs. Medical Therapy as First-line for Treatment of Symptomatic Paroxysmal Atrial Fibrillation: A Systematic Review

Syeda Sehrish Hassan, Abiodun O. Aboaba, Omar Rahim, Shaymaa E. Abdelmalek, Prerna Singh, Taiwo Ogundipe, Probal Talukdar, Gideon Asaolu, Epiniah S. Choga, Daniel Kasho Williams, Bolude Oludele Oluwade, Manel Bouchama, Yishwerer Karadapanddy, Patrick Batti & Adewale Mark Adedoyin · Journal of Advances in Medicine and Medical Research · 2022

Introduction: The outcomes of Catheter Ablation (CA) and antiarrhythmic drugs (AAD) as the first-line treatment of paroxysmal Atrial Fibrillation (AF) are unclear. The current systematic review reports the evidence on efficacy outcomes of Radiofrequency Ablation (RFA) versus anti...

Open access Research Article 10.9734/jammr/2022/v34i2231574

The Potential Role of Colchicine in Reducing Mortality and Mechanical Ventilation Rates in COVID-19 Infection: A Meta-analysis

Shilpa Rai, Shahbaz Singh Nijjar, Blessing T. OJinna, Iqra Mukhtar, Maryam Ahmed, Opeyemi Tobalesi, Prerna Singh, Olamide Adefashola, Abiodun O. Aboaba, Danish Waqar, Jeffrey Ndove, Frederick Ferguson, Adewale Mark Adedoyin, Patrick Batti & Hammad Zafar · Journal of Advances in Medicine and Medical Research · 2022

Background: Colchicine is one of many drugs being repurposed for COVID-19 due to its potential as an anti-inflammatory agent alongside its easy accessibility and oral administration. This study aims to identify the risk reduction in mortality and mechanical ventilation of colchic...

Open access Research Article 10.9734/jammr/2022/v34i2031503